Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Apr 2023 for CymaBay Therapeutics, Inc., €31k. Read the official filing
Filing timeline
BuySaleDennis d. Kim
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Dennis d. Kim: trading record in brief
All filings by Dennis d. Kim on record concern CymaBay Therapeutics, Inc., in the capacity of senior executive. The record holds 3 filings, for trades running from 19 January 2022 to 13 April 2023.
No open-market sale appears; the market trades are 1 purchase worth €54k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises.
On 17 April 2023 came the latest disclosure, an option exercise for €31k in CymaBay Therapeutics, Inc. The most recent open-market purchase was published on 20 January 2022, 1,732 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dennis d. Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
7,781 shares@ US$4.3722.2% of flowCommon StockSEC:0001062993-23-009245:0
100 shares@ US$4.370.3% of flowCommon StockSEC:0001062993-23-008102:0
20,000 shares@ US$3.0463.3% of flowCommon StockSEC:0001062993-22-001295:0
Canonical exit: 19 Apr 2022 (T+90)
3 of 3 declarations
